英文名稱 | Rosiglitazone HCl | BRL 49653 hydrochloride |
---|---|
中文名稱 | 鹽酸羅格列酮 |
CAS號(hào) | 302543-62-0 |
分子式 | C18H19N3O3S·HCl |
分子量 | 393.89 | 357.43 (free) |
外觀 | White to off-white powder |
儲(chǔ)存條件 | -20°C, sealed storage, away from moisture |
規(guī)格 | 庫存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 | |
---|---|---|---|---|---|
暫無牌價(jià)信息,您可以發(fā)送詢價(jià),我們會(huì)盡快給你回復(fù)。 |
英文名稱 | Rosiglitazone HCl | BRL 49653 hydrochloride |
---|---|
中文名稱 | 鹽酸羅格列酮 |
CAS號(hào) | 302543-62-0 |
分子式 | C18H19N3O3S·HCl |
分子量 | 393.89 | 357.43 (free) |
外觀 | White to off-white powder |
儲(chǔ)存條件 | -20°C, sealed storage, away from moisture |
Rosiglitazone (BRL 49653) hydrochloride is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone hydrochloride is a TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone hydrochloride can be used in the research of obesity and diabetes, senescence, ovarian cancer.
PMID: 21406603 PMCID: PMC3102547 DOI: 10.1124/mol.110.069922
Beneficial effects of rosiglitazone and losartan combination in diabetic rats.
PMID: 28892640 DOI: 10.1139/cjpp-2017-0332
PMID: 34182323 DOI: 10.1016/j.intimp.2021.107809
Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib.
PMID: 34182323 DOI: 10.1016/j.intimp.2021.107809